Hjem › Kardiotoxicitet › New Jersey
Kardiotoxicitet kliniske forsøg i New Jersey
4 studier for Kardiotoxicitet søger deltagere på steder i New Jersey.
Officiel studietekst (engelsk)
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Hackensack University Medical Center, Hackensack
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 1. jun. 2026 · NCT06699056A Study of Blood Pressure Control During Cancer Treatment
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RekruttererFase 2
Alder 18 og opefter · Kvinder · Opdateret 14. maj 2026 · NCT06023576Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
- Trinitas Hospital and Comprehensive Cancer Center, Elizabeth
- RWJBarnabas Health - Robert Wood Johnson University Hospital, Hamilton, Hamilton
- RWJBarnabas Health - - Jersey City Medical Medical, Jersey City
- og 7 flere
RekruttererFase 2
Alder 18 og opefter · Kvinder · Opdateret 14. nov. 2025 · NCT05559164S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Morristown Medical Center, Morristown
- Overlook Hospital, Summit
- Holy Name Hospital, Teaneck
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 8. okt. 2025 · NCT03418961Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.